Related Experiment Video
Updated: Aug 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Primary HIV-1 infection: to treat or not to treat?
1Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Treatment of primary HIV-1 infection with HAART may represent a unique opportunity to alter the course of this chronic disease. In spite of this, enthusiasm for the "ht early, hit hard" approach has waned over time, given the lack of data showing long-term clinical benefit. This article will examine the risks and benefits of starting HAART during acute HIV-1 disease.
Treatment of primary HIV-1 infection with HAART may represent a unique opportunity to alter the course of this chronic disease. In spite of this, enthusiasm for the "ht early, hit hard" approach has waned over time, given the lack of data showing long-term clinical benefit. This article will examine the risks and benefits of starting HAART during acute HIV-1 disease.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Herpes
Genital Herpes
Cryptococcal Meningitis
Trichomoniasis

